Humira has become a bona fide mega-blockbuster: 3Q08 sales were $1.2B (nearly a $5B annualized rate), +50% (!) year-over-year and +10% quarter-over-quarter.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”